
Quality and Regulatory Affairs professional with a Master’s degree in Regulatory Affairs and hands-on experience in medical device complaint handling, post-market quality assurance, complaint remediation, CAPA support, and regulatory compliance. Experienced in reviewing and assessing complaint records, identifying potential adverse events, conducting trend analysis, supporting MDR evaluations, and ensuring compliance with FDA 21 CFR Part 820 and ISO 13485 requirements. Proven ability to collaborate with cross-functional teams, manage quality documentation, support post-market surveillance activities, and drive continuous improvement initiatives. Strong analytical, problem-solving, and regulatory knowledge with a background spanning medical devices, quality systems, and healthcare operations.
Diligent [Desired Position] with solid background in ensuring product quality and compliance with industry standards. Proven track record in identifying defects and implementing corrective actions to enhance product reliability. Demonstrated ability in utilizing analytical skills and attention to detail to maintain high-quality benchmarks.
• SOP Development for Non-Conforming Products – Developed comprehensive SOPs for non-conforming product processes, inspection, and labeling for Class II infusion pumps, ensuring adherence to 21 CFR Part 820, ISO 13485, and quality assurance protocols directly applicable to manufacturing quality environments.
• Comprehensive Regulatory Plan for Tandem Insulin – Developed a regulatory plan addressing pre- and post-marketing needs, enhancing critical thinking to navigate regulatory challenges and ensure compliance with industry requirements for manufactured products.
• Phase 4 Clinical Trial Protocol Development – Designed protocol and identified recruitment locations while executing retention strategies for a Phase 4 clinical trial; conducted thorough FDA guidance reviews to ensure regulatory compliance.
• Regulatory Strategy for SemPresto Autoinjector – Developed a regulatory strategy for an innovative emergency epinephrine auto injector, ensuring safety, efficiency, and FDA approval via the 505(b)(2) pathway.